Government ❯ Regulatory Agencies ❯ Health Regulations

Pharmaceutical Oversight

ANMAT Enforcement Actions Anvisa Quality Control ANMAT Decisions Law Enforcement Actions ANMAT Actions Anmat Actions Anmat Public Health Policy

Anvisa Orders Recall of Three Injectable Drug Lots After Contamination and Quality Failures

The regulator said the affected ampoules and saline pose direct bloodstream risks and signalled inspections and further probes to trace the problem

Brazil Plans Anvisa–Federal Police Pact to Crack Down on Illegal Weight-Loss Injections

ANMAT Suspends Global Pharma Group Over Cold-Chain and Traceability Failures

Rio Police Launch Third Phase of Crackdown on Illegal Weight-Loss Drugs

ANMAT Revokes 54 Distributors’ Licenses, Deregisters Two Labs, Restricts Dental y Mediquil Sales

ANMAT Revokes Four Lab Licenses, Bans Unregistered Products, Halts LADECE Production

ANMAT Bans P.L. Rivero Injectables Made at Solkotal as Enforcement Drive Expands

ANMAT Shuts Laboratorios Beta and Pulls Ten Exotran Lots Over Quality Failures

Malbrán Details Possible Contamination Points as Fentanyl Deaths Probe Nears Key Rulings

ANMAT Suspends Production at Sant Gall Friburg’s Buenos Aires Plant Over GMP Breaches